Expertise · Clinical & Preclinical Studies

Using Foreign Clinical Studies for EAEU Registration: When a GCP Inspection Can Replace a New Local Trial

Development programmes supporting medicinal product registration

This section brings together clinical, bioequivalence and preclinical evidence used to support medicinal product registration, including local-study strategy, foreign-data usability, GCP/GLP inspection risk, biowaivers and biological products.

Detailed guidance across the evidence programme is available in the current technical library.

Foreign clinical studies for EAEU registration and GCP inspection pathway
Loading…